loading
전일 마감가:
$0.5792
열려 있는:
$0.559
하루 거래량:
135.94K
Relative Volume:
0.36
시가총액:
$18.77M
수익:
$3.04M
순이익/손실:
$-33.97M
주가수익비율:
-0.4205
EPS:
-1.33
순현금흐름:
$-52.47M
1주 성능:
-9.34%
1개월 성능:
-49.62%
6개월 성능:
-72.32%
1년 성능:
-89.08%
1일 변동 폭
Value
$0.5505
$0.5979
1주일 범위
Value
$0.5505
$0.647
52주 변동 폭
Value
$0.4619
$5.7399

Rani Therapeutics Holdings Inc Stock (RANI) Company Profile

Name
명칭
Rani Therapeutics Holdings Inc
Name
전화
(408) 457-3700
Name
주소
2051 RINGWOOD AVENUE, SAN JOSE
Name
직원
106
Name
트위터
Name
다음 수익 날짜
2025-03-31
Name
최신 SEC 제출 서류
Name
RANI's Discussions on Twitter

RANI을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
RANI
Rani Therapeutics Holdings Inc
0.5592 20.71M 3.04M -33.97M -52.47M -1.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Rani Therapeutics Holdings Inc Stock (RANI) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-08-02 개시 Oppenheimer Outperform
2024-06-14 개시 Maxim Group Buy
2024-06-13 개시 Rodman & Renshaw Buy
2023-04-17 재개 BTIG Research Buy
2022-10-11 개시 UBS Buy
2022-07-27 개시 H.C. Wainwright Buy
2022-06-13 개시 Wedbush Outperform
모두보기

Rani Therapeutics Holdings Inc 주식(RANI)의 최신 뉴스

pulisher
May 29, 2025

Rani Therapeutics announces annual meeting results By Investing.com - Investing.com Nigeria

May 29, 2025
pulisher
May 29, 2025

Rani Therapeutics announces annual meeting results - Investing.com

May 29, 2025
pulisher
May 29, 2025

Rani Therapeutics Approves Key Proposals at Annual Meeting - TipRanks

May 29, 2025
pulisher
May 25, 2025

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives $9.40 Consensus PT from Brokerages - Defense World

May 25, 2025
pulisher
May 23, 2025

What is Zacks Small Cap’s Estimate for RANI Q3 Earnings? - Defense World

May 23, 2025
pulisher
May 22, 2025

Q2 Earnings Estimate for RANI Issued By Zacks Small Cap - Defense World

May 22, 2025
pulisher
May 21, 2025

Rani Therapeutics (NASDAQ:RANI) Stock Price Up 7% – Here’s What Happened - Defense World

May 21, 2025
pulisher
May 20, 2025

Rani Therapeutics Secures $4.3M via Series D Warrant - TipRanks

May 20, 2025
pulisher
May 20, 2025

Rani Therapeutics strikes deal to issue new warrants - Investing.com

May 20, 2025
pulisher
May 20, 2025

Rani Therapeutics strikes deal to issue new warrants By Investing.com - Investing.com UK

May 20, 2025
pulisher
May 20, 2025

Rani Therapeutics Announces Research Agreement with Chugai - GlobeNewswire

May 20, 2025
pulisher
May 19, 2025

Rani Therapeutics explores oral delivery of Chugai’s drugs - Investing.com Australia

May 19, 2025
pulisher
May 19, 2025

RANI: 1Q:25 Financial Results - MSN

May 19, 2025
pulisher
May 19, 2025

Rani Therapeutics (RANI) Partners with Chugai for Innovative Research | RANI Stock News - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Rani Therapeutics explores oral delivery of Chugai’s drugs By Investing.com - Investing.com India

May 19, 2025
pulisher
May 19, 2025

Rani Therapeutics Enters Research Agreement with Chugai Pharmaceutical to Explore Oral Delivery Technology for Antibody Development - Nasdaq

May 19, 2025
pulisher
May 19, 2025

Breakthrough: Rani's Oral Biologics Platform Matches Injectable Drugs in Chugai Partnership Study - Stock Titan

May 19, 2025
pulisher
May 18, 2025

Oppenheimer Has Lowered Expectations for Rani Therapeutics (NASDAQ:RANI) Stock Price - Defense World

May 18, 2025
pulisher
May 16, 2025

RANI Stock Update: Analyst Maintains Rating, Lowers Price Target | RANI Stock News - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Oppenheimer cuts Rani Therapeutics target to $4, keeps Outperform - Investing.com Australia

May 16, 2025
pulisher
May 16, 2025

Oppenheimer cuts Rani Therapeutics target to $4, keeps Outperform By Investing.com - Investing.com Nigeria

May 16, 2025
pulisher
May 16, 2025

Oppenheimer Adjusts Rani Therapeutics Price Target to $4 From $14, Maintains Outperform Rating - marketscreener.com

May 16, 2025
pulisher
May 16, 2025

Oppenheimer Adjusts Rani Therapeutics (RANI) Price Target | RANI Stock News - GuruFocus

May 16, 2025
pulisher
May 15, 2025

Rani Therapeutics Highlights Promising Preclinical Data - TipRanks

May 15, 2025
pulisher
May 13, 2025

Rani Therapeutics Q1 2025 Earnings: EPS Misses at -$0.22, Revenue Surpasses Estimates at $0.2 Million - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Rani Therapeutics Reports First Quarter 2025 Financial Results; Provides Corporate Update - GlobeNewswire

May 13, 2025
pulisher
May 13, 2025

Rani Therapeutics Q1 Net Income USD -12.738 Million - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Rani Therapeutics Holdings, Inc. SEC 10-Q Report - TradingView

May 13, 2025
pulisher
May 13, 2025

Rani Therapeutics Achieves Major Milestone: Oral Obesity Drug Shows Equal Success to Injections in Latest Data - Stock Titan

May 13, 2025
pulisher
May 08, 2025

Ratio Analysis: Unpacking Rani Therapeutics Holdings Inc (RANI)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX

May 08, 2025
pulisher
May 07, 2025

Rani Therapeutics faces Nasdaq delisting over market value By Investing.com - Investing.com India

May 07, 2025
pulisher
May 06, 2025

Rani Therapeutics faces Nasdaq delisting over market value - Investing.com

May 06, 2025
pulisher
May 06, 2025

Rani Therapeutics Faces Nasdaq Compliance Challenge - TipRanks

May 06, 2025
pulisher
May 05, 2025

Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update - ADVFN

May 05, 2025
pulisher
May 03, 2025

Rani Therapeutics (RANI) Expected to Announce Quarterly Earnings on Monday - Defense World

May 03, 2025
pulisher
Apr 30, 2025

Rani Therapeutics Board Restructures After DeBuono’s Retirement - TipRanks

Apr 30, 2025
pulisher
Apr 28, 2025

Ratio Examination: Rani Therapeutics Holdings Inc (RANI)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX

Apr 28, 2025
pulisher
Apr 28, 2025

Daily Progress: XPLR Infrastructure LP (XIFR) Drop -1.51, Closing at 8.46 - DWinneX

Apr 28, 2025
pulisher
Apr 28, 2025

Market Recap: PowerFleet Inc (AIOT)’s Negative Momentum, Closing at 5.12 - DWinneX

Apr 28, 2025
pulisher
Apr 28, 2025

Market Highlights: Clear Channel Outdoor Holdings Inc (CCO) Ends on a Low Note at 1.02 - DWinneX

Apr 28, 2025
pulisher
Apr 28, 2025

Post-Trade Analysis: Baytex Energy Corp (BTE) Climbs 0.61, Closing at 1.65 - DWinneX

Apr 28, 2025
pulisher
Apr 27, 2025

Brokerages Set Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Target Price at $12.33 - Defense World

Apr 27, 2025
pulisher
Apr 16, 2025

SEC Form DEFA14A filed by Rani Therapeutics Holdings Inc. - Quantisnow

Apr 16, 2025
pulisher
Apr 05, 2025

HC Wainwright Reaffirms “Buy” Rating for Rani Therapeutics (NASDAQ:RANI) - Defense World

Apr 05, 2025
pulisher
Apr 04, 2025

What is Zacks Small Cap’s Forecast for RANI FY2025 Earnings? - Defense World

Apr 04, 2025
pulisher
Apr 02, 2025

Rani Therapeutics stock hits 52-week low at $1.24 - Investing.com Australia

Apr 02, 2025
pulisher
Apr 02, 2025

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives $12.33 Consensus PT from Analysts - Defense World

Apr 02, 2025
pulisher
Apr 01, 2025

Rani Therapeutics Earnings Call: Tech Gains Amid Financial Strains - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

BTIG maintains Buy on Rani Therapeutics stock, $14 target - Investing.com Australia

Apr 01, 2025

Rani Therapeutics Holdings Inc (RANI) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
자본화:     |  볼륨(24시간):